Peter Heerma, CHIEF COMMERCIAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 10,332 shares at $20.12 ($208K) on 2025-02-03, disclosed to the SEC on 2025-02-04.
Seasonal sale ($208k) by CHIEF COMMERCIAL OFFICER — this insider has traded TVTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.12 | 5,166 | $104K | 50.0% |
| 2 | $20.12 | 5,166 | $104K | 50.0% |
| Total | $20.12 avg | 10,332 | $208K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $303K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $235K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |